(Q34396312)
Statements
Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries (English)
Andrew Hill
Saye Khoo
Joe Fortunak
1 reference
1 reference
1 reference
1 reference